Schnakers C, Monti MM. Disorders of consciousness after severe brain injury: therapeutic options. Curr Opin Neurol. 2017;30(6):573–9.

Article  PubMed  Google Scholar 

Edlow BL, Sanz LR, Polizzotto L, Pouratian N, Rolston JD, Snider SB, et al. Curing Coma Campaign and its contributing members. Therapies to restore consciousness in patients with severe brain injuries: a gap analysis and future directions. Neurocrit Care. 2021;35(Supp 1):68–85.

Article  PubMed  PubMed Central  Google Scholar 

Luppi AI, Cain J, Spindler LR, Górska UJ, Toker D, Hudson AE, et al. Curing coma campaign and its contributing collaborators. Mechanisms underlying disorders of consciousness: bridging gaps to move toward an integrated translational science. Neurocrit Care. 2021;35(Suppl 1):37–54.

Article  PubMed  PubMed Central  Google Scholar 

Schiff ND. Mesocircuit mechanisms underlying recovery of consciousness following severe brain injuries: model and predictions. In: Monti M, Sannita W, editors. Brain function and responsiveness in disorders of consciousness. Cham: Springer; 2016. p. 195–204. https://doi.org/10.1007/978-3-319-21425-2_15.

Chapter  Google Scholar 

Giacino JT, Fins JJ, Laureys S, Schiff ND. Disorders of consciousness after acquired brain injury: the state of the science. Nat Rev Neurol. 2014;10(2):99–114.

Article  PubMed  Google Scholar 

Stender J, Gosseries O, Bruno MA, Charland-Verville V, Vanhaudenhuyse A, Demertzi A, et al. Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study. Lancet. 2014;384(9942):514–22.

Article  PubMed  Google Scholar 

Tommasino C, Grana C, Lucignani G, Torri G, Fazio F. Regional cerebral metabolism of glucose in comatose and vegetative state patients. J Neurosurg Anesthesiol. 1995;7(2):109–16.

Article  CAS  PubMed  Google Scholar 

Edlow BL, Claassen J, Schiff ND, Greer DM. Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies. Nat Rev Neurol. 2021;17(3):135–56.

Article  PubMed  Google Scholar 

Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth. 2007;99(1):4–9.

Article  CAS  PubMed  Google Scholar 

Hazell AS. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int. 2007;50(7–8):941–53.

Article  CAS  PubMed  Google Scholar 

Pistoia F, Sarà M, Sacco S, Franceschini M, Carolei A. Silencing the brain may be better than stimulating it. The GABA effect. Curr Pharm Des. 2014;20(26):4154–66.

CAS  PubMed  Google Scholar 

Ciurleo R, Bramanti P, Calabrò RS. Pharmacotherapy for disorders of consciousness: are ‘awakening’ drugs really a possibility? Drugs. 2013;73(17):1849–62.

Article  CAS  PubMed  Google Scholar 

Vidale S, Consoli A, Arnaboldi M, Consoli D. Postischemic inflammation in acute stroke. J Clin Neurol. 2017;13(1):1–9.

Article  PubMed  Google Scholar 

Emsley HC, Smith CJ, Tyrrell PJ, Hopkins SJ. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit Care. 2008;9(1):125–38.

Article  CAS  PubMed  Google Scholar 

Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care. 2002;8(2):101–5.

Article  PubMed  Google Scholar 

Loane DJ, Kumar A, Stoica BA, Cabatbat R, Faden AI. Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol. 2014;73(1):14–29.

Article  CAS  PubMed  Google Scholar 

Nagamoto-Combs K, McNeal DW, Morecraft RJ, Combs CK. Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury. J Neurotrauma. 2007;24(11):1719–42.

Article  PubMed  Google Scholar 

Stuckey SM, Ong LK, Collins-Praino LE, Turner RJ. Neuroinflammation as a key driver of secondary neurodegeneration following stroke? Int J Mol Sci. 2021;22(23):13101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baumann CR, Stocker R, Imhof HG, Trentz O, Hersberger M, Mignot E, et al. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology. 2005;65(1):147–9.

Article  CAS  PubMed  Google Scholar 

Skopin MD, Kabadi SV, Viechweg SS, Mong JA, Faden AI. Chronic decrease in wakefulness and disruption of sleep-wake behavior after experimental traumatic brain injury. J Neurotrauma. 2015;32(5):289–96.

Article  PubMed  PubMed Central  Google Scholar 

Hu S, Ren L, Wang Y, Lei Z, Cai J, Pan S. The association between serum orexin A and short-term neurological improvement in patients with mild to moderate acute ischemic stroke. Brain Behav. 2023;13(1): e2845.

Article  CAS  PubMed  Google Scholar 

Korley FK, Diaz-Arrastia R, Wu AH, Yue JK, Manley GT, Sair HI, et al. TRACK-TBI investigators. Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury. J Neurotrauma. 2016;33(2):215–25.

Article  PubMed  PubMed Central  Google Scholar 

Stanne TM, Åberg ND, Nilsson S, Jood K, Blomstrand C, Andreasson U, et al. Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke. Stroke. 2016;47(7):1943–5.

Article  CAS  PubMed  Google Scholar 

Bagnato S, Galardi G, Ribaudo F, Boccagni C, Fiorilla TV, Rubino F, et al. Serum BDNF levels are reduced in patients with disorders of consciousness and are not modified by verticalization with robot-assisted lower-limb training. Neural Plast. 2020;2020:5608145.

Article  PubMed  PubMed Central  Google Scholar 

Yang WJ, Chen W, Chen L, Guo YJ, Zeng JS, Li GY, et al. Involvement of tau phosphorylation in traumatic brain injury patients. Acta Neurol Scand. 2017;135(6):622–7.

Article  CAS  PubMed  Google Scholar 

Goulay R, Mena Romo L, Hol EM, Dijkhuizen RM. From stroke to dementia: a comprehensive review exposing tight interactions between stroke and amyloid-β formation. Transl Stroke Res. 2020;11(4):601–14.

Article  PubMed  Google Scholar 

Russell CL, Semerdjieva S, Empson RM, Austen BM, Beesley PW, Alifragis P. Amyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2. PLoS ONE. 2012;7(8): e43201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, et al. Alzheimer’s disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J Neurosci. 2011;31(20):7259–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Donnell JC, Browne KD, Kilbaugh TJ, Chen HI, Whyte J, Cullen DK. Challenges and demand for modeling disorders of consciousness following traumatic brain injury. Neurosci Biobehav Rev. 2019;98:336–46.

Article  PubMed  Google Scholar 

Ren F, Aliper A, Chen J, Zhao H, Rao S, Kuppe C, et al. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat Biotechnol. 2025;43(1):63–75.

Article  CAS  PubMed  Google Scholar 

Stokes JM, Yang K, Swanson K, Jin W, Cubillos-Ruiz A, Donghia NM, et al. A deep learning approach to antibiotic discovery. Cell. 2020;180(4):688-702.e13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moffat JG, Vincent F, Lee JA, Eder J, Prunotto M. Opportunities and challenges in phe